ROYAL BANK OF CANADA - DIPEXIUM PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of DIPEXIUM PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2017$04
-96.0%
0.00%
Q4 2016$01000.00%
Other shareholders
DIPEXIUM PHARMACEUTICALS INC shareholders Q2 2017
NameSharesValueWeighting ↓
Park West Asset Management LLC 194,340$253,0000.02%
MIDDLETON & CO INC/MA 15,848$21,0000.01%
Acrospire Investment Management LLC 4,220$5,0000.00%
Tower Research Capital LLC (TRC) 19,942$26,0000.00%
A.R.T. Advisors, LLC 32,426$42,0000.00%
FNY Partners Fund LP 500$5,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 43,447$56,0000.00%
Raymond James Financial Services Advisors, Inc. 13,200$17,0000.00%
GOLDMAN SACHS GROUP INC 24,378$32,0000.00%
MORGAN STANLEY 7,566$10,0000.00%
View complete list of DIPEXIUM PHARMACEUTICALS INC shareholders